BioTech Scout

Discover the most promising early-stage companies in life sciences, scouted by BioPharmaTrend. Follow company news and important business events.

back to Directory

BrainStorm Cell Therapeutics

BrainStorm Cell Therapeutics logo

Founded
2004
Patents
10
Clinical Trials
5
Publications
10

Technologies

Stem Cells Startups

BrainStorm Cell Therapeutics is a biotechnology company developing innovative, autologous stem cell therapies for highly debilitating neurodegenerative diseases such as Amyotrophic Lateral Sclerosis (ALS, also known as Lou Gehrig's disease), Multiple Sclerosis (MS) and Parkinson’s Disease (PD).

Posts Mentioning This Company

Mesenchymal Stem Cells to Battle COVID-19

  
What is a Mesenchymal Stem Cell? What Can it Do? Mesenchymal stem cells (MSCs) are multipotent stem/progenitor cells that are present in different tissues, including the umbilical cord, bone marrow, and fat tissue. MSCs can self-renew by dividing and differentiate into cells of bone, cartilage, muscle and fat cells, and …
The Promise Of Cell Therapies And Top Biotechs Riding The Wave

The Promise Of Cell Technologies In Immunotherapy

  
The number of immunotherapies in clinical trial rolls over 5000 now, and immunology has become a common approach in some cancers. Cell technologies, as a growing sub-field in the immunotherapy landscape, have progressed considerably and now represent a $26 billion financial opportunity by 2030, according to a report by Roots …